CAM
PTCT icon

ClariVest Asset Management’s PTC Therapeutics PTCT Stock Holding History

ClariVest Asset Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,677
Closed -$452K – 811
2021
Q2 		$452K Buy
10,677
+26
+0.2% +$1.11K 0.02% 440
2021
Q1 		$504K Sell
10,651
-600
-5% -$35.6K 0.02% 411
2020
Q4 		$687K Sell
11,251
-15,348
-58% -$905K 0.02% 325
2020
Q3 		$1.24M Sell
26,599
-1,162
-4% -$57.2K 0.04% 283
2020
Q2 		$1.41M Sell
27,761
-818
-3% -$40.2K 0.04% 277
2020
Q1 		$1.27M Sell
28,579
-42
-0.1% -$2.12K 0.04% 258
2019
Q4 		$1.37M Sell
28,621
-18,933
-40% -$805K 0.03% 307
2019
Q3 		$1.61M Sell
47,554
-600
-1% -$26.1K 0.04% 281
2019
Q2 		$2.17M Sell
48,154
-400
-0.8% -$15.8K 0.05% 242
2019
Q1 		$1.83M Sell
48,554
-37,690
-44% -$1.27M 0.04% 327
2018
Q4 		$2.96M Buy
86,244
+19,270
+29% +$693K 0.06% 240
2018
Q3 		$3.15M Buy
66,974
+5,393
+9% +$223K 0.06% 248
2018
Q2 		$2.08M Buy
+61,581
New +$1.92M 0.04% 338

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClariVest Asset Management's PTCT Position: Q3 2021 in Review

ClariVest Asset Management sold out of PTC Therapeutics (PTCT) in Q3 2021, closing a stake of 10,677 shares — an estimated $452K sold.

ClariVest Asset Management first reported a position in PTCT in Q2 2018 and held it in 13 quarters. The position peaked at $3.15M in Q3 2018. 182 funds tracked by Wall St. Rank hold PTCT as of Q3 2021.

  • ClariVest Asset Management reported no remaining PTC Therapeutics position as of Q3 2021 after selling out during the quarter.
  • ClariVest Asset Management sold 10,677 PTC Therapeutics shares in Q3 2021, an estimated $452K.
  • ClariVest Asset Management first reported a position in PTC Therapeutics in Q2 2018 and held it in 13 quarters.
  • ClariVest Asset Management's PTC Therapeutics position peaked at $3.15M in Q3 2018.
  • 182 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2021.

Based on ClariVest Asset Management's 13F filing for Q3 2021, filed 8 Nov 2021.